Expertise in
4
conditions

Radoslaw Kempinski

Wroclaw, DS, PL 
Expertise in
4
conditions
Wroclaw, DS, PL 

Overview

Radoslaw Kempinski practices practicing medicine in Wroclaw, Poland.

Kempinski is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Hemorrhagic Proctocolitis, Ulcerative Colitis, Colitis, Endoscopy, and Colonoscopy.

They are actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 2 clinical trials.

Locations

Wroclaw, DS, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Unknown
Publish Date: September 05, 2023
Intervention Type: Drug
Study Drug: SHR0302
Study Phase: Phase 3
Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy for Adenoma Detection: A Randomized Controlled European Multicenter Study
Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy for Adenoma Detection: A Randomized Controlled European Multicenter Study
Enrollment Status: Completed
Publish Date: February 12, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

31 Total Publications

Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trial.
Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trial.
Journal: Journal of Crohn's & colitis
Published: May 11, 2026

Frequently Asked Questions about Radoslaw Kempinski

Is Radoslaw Kempinski a top-rated expert for Hemorrhagic Proctocolitis?

MediFind is an objective health platform that identifies experts based on real-world data. Radoslaw Kempinski is classified as an Advanced expert for Hemorrhagic Proctocolitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Radoslaw Kempinski participate in research or clinical trials?

Yes. Radoslaw Kempinski has published 31 articles and abstracts on conditions like Hemorrhagic Proctocolitis. You can view a list of Radoslaw Kempinski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kempinski's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile